Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Masked, Two-Part, Placebo-Controlled Phase 2A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 for the Treatment of Inflammation and Pain After Cataract Surgery

NCT04089735 is registered in ClinicalTrials.gov with Formosa Pharmaceuticals, Inc. as lead sponsor.

NCT NCT04089735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04089735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Masked, Two-Part, Placebo-Controlled Phase 2A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 for the Treatment of Inflammation and Pain After Cataract Surgery
Lead sponsor
Formosa Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
August 13, 2019
Completion date
April 7, 2020
Enrollment
165 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

ocular inflammation and pain after cataract surgery